|
State of Israel
|
| |
7372
|
| |
Not Applicable
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification No.) |
|
|
Joshua G. Kiernan
Marc D. Jaffe Ian D. Schuman Latham & Watkins LLP 1271 Avenue of the Americas New York, New York 10020 Tel: (212) 906-1200 Fax: (212) 751-4864 |
| |
Shachar Hadar
Efrat Ziv Ran Camchy Meitar | Law Offices 16 Abba Hillel Road Ramat Gan, 5250608, Israel Tel: +972(3) 610-3100 Fax: +972(3) 610-3111 |
| |
Yossi Vebman
Ryan J. Dzierniejko Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, New York 10001 Tel: (212) 735-3000 Fax: (212) 735-2000 |
| |
Chaim Friedland
Ari Fried Nir Knoll Gornitzky & Co. Vitania Tel-Aviv Tower 20 HaHarash St. Tel Aviv 6761310, Israel Tel: +972(3) 710-9191 Fax: +972(3) 560-6555 |
|
| | |||||||||||
Title of Each Class of Securities to be Registered
|
| | |
Proposed
Maximum Aggregate Offering Price(1)(2) |
| | |
Amount of
Registration Fee(3) |
| |||
Ordinary shares, no par value
|
| | |
$100,000,000.00
|
| | | | $ | 10,910.00 | | |
| Shares | | |
Ordinary Shares
|
|
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price | | | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(1) | | | | $ | | | | | $ | | | ||
Proceeds to us (before expenses) | | | | $ | | | | | $ | | | |
|
Goldman Sachs & Co. LLC
|
| |
J.P. Morgan
|
|
|
Allen & Company LLC
|
| |
Jefferies
|
|
|
William Blair
|
| |
Piper Sandler
|
| |
Oppenheimer & Co.
|
| |
Canaccord Genuity
|
| |
Cowen
|
| |
Needham & Company
|
|
| | | | | 1 | | | |
| | | | | 18 | | | |
| | | | | 61 | | | |
| | | | | 63 | | | |
| | | | | 64 | | | |
| | | | | 65 | | | |
| | | | | 66 | | | |
| | | | | 67 | | | |
| | | | | 69 | | | |
| | | | | 94 | | | |
| | | | | 123 | | | |
| | | | | 150 | | | |
| | | | | 153 | | | |
| | | | | 156 | | | |
| | | | | 166 | | | |
| | | | | 170 | | | |
| | | | | 178 | | | |
| | | | | 184 | | | |
| | | | | 185 | | | |
| | | | | 186 | | | |
| | | | | 187 | | | |
| | | | | 189 | | | |
| | | | | F-1 | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands, except for share and per share data)
|
| |||||||||||||||||||||
Revenue
|
| | | $ | 78,089 | | | | | $ | 161,123 | | | | | $ | 31,929 | | | | | $ | 58,972 | | |
Cost of revenue(1)
|
| | | | 11,978 | | | | | | 22,488 | | | | | | 4,591 | | | | | | 7,924 | | |
Gross profit
|
| | | | 66,111 | | | | | | 138,635 | | | | | | 27,338 | | | | | | 51,048 | | |
Operating expenses:
|
| | | | | | | | | | | | | | | ||||||||||
Research and development(1)
|
| | | | 24,637 | | | | | | 43,480 | | | | | | 6,651 | | | | | | 15,581 | | |
Sales and marketing(1)
|
| | | | 118,534 | | | | | | 191,353 | | | | | | 36,945 | | | | | | 63,048 | | |
General and administrative(1)
|
| | | | 15,458 | | | | | | 54,339 | | | | | | 3,745 | | | | | | 10,266 | | |
Total operating expenses
|
| | | | 158,629 | | | | | | 289,172 | | | | | | 47,341 | | | | | | 88,895 | | |
Operating loss
|
| | | | (92,518) | | | | | | (150,537) | | | | | | (20,003) | | | | | | (37,847) | | |
Financial income (expense), net
|
| | | | 1,590 | | | | | | 526 | | | | | | 349 | | | | | | (406) | | |
Loss before income taxes
|
| | | | (90,928) | | | | | | (150,011) | | | | | | (19,654) | | | | | | (38,253) | | |
Income tax expense
|
| | | | (683) | | | | | | (2,192) | | | | | | (209) | | | | | | (699) | | |
Net loss
|
| | | $ | (91,611) | | | | | $ | (152,203) | | | | | $ | (19,863) | | | | | $ | (38,952) | | |
Net loss per share attributable to ordinary
shareholders’, basic and diluted(2) |
| | | $ | (9.22) | | | | | $ | (14.19) | | | | | $ | (2.08) | | | | | $ | (3.52) | | |
Weighted-average ordinary shares used in
calculating net loss per ordinary share, basic and diluted |
| | | | 11,348,428 | | | | | | 12,048,909 | | | | | | 11,778,108 | | | | | | 12,392,298 | | |
Pro forma net loss per share(2)
|
| | | | | | | | | $ | (3.95) | | | | | $ | (0.52) | | | | | $ | (1.00) | | |
Weighted-average shares used in
calculating pro forma net loss per share, basic and diluted(2) |
| | | | | | | | | | 38,489,148 | | | | | | 38,218,347 | | | | | | 38,832,537 | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Cost of revenue
|
| | | $ | 970 | | | | | $ | 2,720 | | | | | $ | 299 | | | | | $ | 1,531 | | |
Research and development
|
| | | | 9,396 | | | | | | 12,142 | | | | | | 1,025 | | | | | | 4,537 | | |
Sales and marketing
|
| | | | 3,283 | | | | | | 10,068 | | | | | | 1,051 | | | | | | 4,034 | | |
General and administrative
|
| | | | 8,190 | | | | | | 39,415 | | | | | | 851 | | | | | | 4,438 | | |
Total share-based compensation expense
|
| | | $ | 21,839 | | | | | $ | 64,345 | | | | | $ | 3,226 | | | | | $ | 14,540 | | |
| | |
As of March 31, 2021
|
| |||||||||||||||
| | |
Actual
|
| |
Pro Forma(1)
|
| |
Pro Forma
As Adjusted(2) |
| |||||||||
| | |
(in thousands)
|
| |||||||||||||||
Cash and cash equivalents
|
| | | $ | 124,281 | | | | | $ | 124,281 | | | | | $ | | | |
Short term deposits
|
| | | | 10,000 | | | | | | 10,000 | | | | | | | | |
Total assets
|
| | | | 160,479 | | | | | | 160,479 | | | | | | | | |
Total liabilities
|
| | | | 168,125 | | | | | | 168,125 | | | | | | | | |
Convertible preferred shares
|
| | | | 233,496 | | | | | | — | | | | | | | | |
Additional paid-in capital
|
| | | | 114,176 | | | | | | 347,672 | | | | | | | | |
Accumulated deficit
|
| | | | (355,318) | | | | | | (355,318) | | | | | | | | |
Total shareholders’ (deficit) equity
|
| | | | (241,142) | | | | | | (7,646) | | | |
|
|
| | |
Year ended
December 31, |
| |
Three months
ended March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Non-GAAP operating loss
|
| | | $ | (70,679) | | | | | $ | (86,192) | | | | | $ | (16,777) | | | | | $ | (23,307) | | |
Adjusted free cash flow
|
| | | | (38,417) | | | | | | (40,692) | | | | | | (5,959) | | | | | | (1,595) | | |
| | |
As of March 31, 2021
|
| |||||||||||||||
| | |
Actual
|
| |
Pro Forma
|
| |
Pro Forma As
Adjusted(1) |
| |||||||||
| | |
(in thousands, except share amounts)
|
| |||||||||||||||
Cash and cash equivalents
|
| | | $ | 124,281 | | | | | $ | 124,281 | | | | | $ | | | |
Preferred shares, no par value: 27,056,939 shares authorized; 26,440,239 shares issued and outstanding, actual; no shares issued and outstanding, pro forma and pro forma as adjusted
|
| | | | 233,496 | | | | | | — | | | | | | | | |
Shareholders’ equity (deficit): | | | | | | | | | | | | | | | | | | | |
Ordinary shares, no par value: 52,943,061 shares authorized, 12,451,895 shares issued and outstanding, actual; 80,000,000 shares authorized, pro forma and pro forma as adjusted; 38,892,134 shares issued and outstanding, pro forma; shares issued and outstanding, pro forma as adjusted
|
| | | | — | | | | | | — | | | | | | | | |
Additional paid-in capital
|
| | | | 114,176 | | | | | | 347,672 | | | | | | | | |
Accumulated deficit
|
| | | | (355,318) | | | | | | (355,318) | | | | | | | | |
Total shareholders’ (deficit) equity
|
| | | | (241,142) | | | | | | (7,646) | | | | | | | | |
Total capitalization
|
| | | $ | (7,646) | | | | | $ | (7,646) | | | | | $ | | | |
|
Assumed initial public offering price per ordinary share
|
| | | | | | | | | $ | | | |
|
Historical net tangible book value per ordinary share as of March 31, 2021
|
| | | $ | | | | | | | | | |
|
Increase per ordinary share attributable to the pro forma adjustments described
above |
| | | | | | | | | | | | |
|
Pro forma net tangible book value per share as of March 31, 2021
|
| | | | | | | | | | | | |
|
Increase in pro forma net tangible book value per ordinary share attributable to this offering
|
| | | | | | | | | | | | |
|
Pro forma as adjusted net tangible book value per ordinary share after this
offering |
| | | | | | | | | | | | |
|
Dilution per ordinary share to new investors in this offering
|
| | | | | | | | | $ | | |
| | |
Ordinary Shares
Purchased |
| |
Total Consideration
|
| |
Average
Price Per Ordinary Share |
| |||||||||||||||||||||
| | |
Number
|
| |
Percent
|
| |
Amount
|
| |
Percent
|
| ||||||||||||||||||
Existing shareholders
|
| | | | | | | | | | % | | | | | $ | | | | | | % | | | | | $ | | | ||
New investors
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total
|
| | | | | | | | | 100% | | | | | | | | | | | | 100% | | | | | | | | |
| | |
Year ended December 31,
|
| |
Three months ended March 31,
|
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Revenue
|
| | | $ | 78,089 | | | | | $ | 161,123 | | | | | $ | 31,929 | | | | | $ | 58,972 | | |
Cost of revenue(1)
|
| | | | 11,978 | | | | | | 22,488 | | | | | | 4,591 | | | | | | 7,924 | | |
Gross profit
|
| | | | 66,111 | | | | | | 138,635 | | | | | | 27,338 | | | | | | 51,048 | | |
Operating Expenses:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Research and development(1)
|
| | | | 24,637 | | | | | | 43,480 | | | | | | 6,651 | | | | | | 15,581 | | |
Sales and marketing(1)
|
| | | | 118,534 | | | | | | 191,353 | | | | | | 36,945 | | | | | | 63,048 | | |
General and administrative(1)
|
| | | | 15,458 | | | | | | 54,339 | | | | | | 3,745 | | | | | | 10,266 | | |
Total operating expenses
|
| | | | 158,629 | | | | | | 289,172 | | | | | | 47,341 | | | | | | 88,895 | | |
Operating loss
|
| | | | (92,518) | | | | | | (150,537) | | | | | | (20,003) | | | | | | (37,847) | | |
Financial income (expense), net
|
| | | | 1,590 | | | | | | 526 | | | | | | 349 | | | | | | (406) | | |
Loss before income taxes
|
| | | | (90,928) | | | | | | (150,011) | | | | | | (19,654) | | | | | | (38,253) | | |
Income tax expenses
|
| | | | (683) | | | | | | (2,192) | | | | | | (209) | | | | | | (699) | | |
Net loss
|
| | | $ | (91,611) | | | | | $ | (152,203) | | | | | $ | (19,863) | | | | | $ | (38,952) | | |
| | |
Year ended December 31
|
| |
Three months ended March 31,
|
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Cost of revenue
|
| | | $ | 970 | | | | | $ | 2,720 | | | | | $ | 299 | | | | | $ | 1,531 | | |
Research and development
|
| | | | 9,396 | | | | | | 12,142 | | | | | | 1,025 | | | | | | 4,537 | | |
Sales and marketing
|
| | | | 3,283 | | | | | | 10,068 | | | | | | 1,051 | | | | | | 4,034 | | |
General and administrative
|
| | | | 8,190 | | | | | | 39,415 | | | | | | 851 | | | | | | 4,438 | | |
Total share-based compensation expense
|
| | | $ | 21,839 | | | | | $ | 64,345 | | | | | $ | 3,226 | | | | | $ | 14,540 | | |
| | |
Year ended
December 31 |
| |
Three months
ended March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
Revenue
|
| | | | 100% | | | | | | 100% | | | | | | 100% | | | | | | 100% | | |
Cost of revenue
|
| | | | 15 | | | | | | 14 | | | | | | 14 | | | | | | 13 | | |
Gross profit
|
| | | | 85 | | | | | | 86 | | | | | | 86 | | | | | | 87 | | |
Operating Expenses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development
|
| | | | 31 | | | | | | 27 | | | | | | 21 | | | | | | 26 | | |
Sales and marketing
|
| | | | 152 | | | | | | 119 | | | | | | 116 | | | | | | 107 | | |
General and administrative
|
| | | | 20 | | | | | | 33 | | | | | | 12 | | | | | | 18 | | |
Total operating expenses
|
| | | | 203 | | | | | | 179 | | | | | | 149 | | | | | | 151 | | |
Operating loss
|
| | | | (118) | | | | | | (93) | | | | | | (63) | | | | | | (64) | | |
Financial income (expense), net
|
| | | | 2 | | | | | | — | | | | | | 1 | | | | | | (1) | | |
Loss before income taxes
|
| | | | (116) | | | | | | (93) | | | | | | (62) | | | | | | (65) | | |
Income tax expenses
|
| | | | (1) | | | | | | (1) | | | | | | — | | | | | | (1) | | |
Net loss
|
| | | | (117)% | | | | | | (94)% | | | | | | (62)% | | | | | | (66)% | | |
| | |
Three months ended
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
June 30,
2019 |
| |
September 30,
2019 |
| |
December 31,
2019 |
| |
March 31,
2020 |
| |
June 30,
2020 |
| |
September 30,
2020 |
| |
December 31,
2020 |
| |
March 31,
2021 |
| ||||||||||||||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||||||||||||||||||||||||||
Revenue
|
| | | $ | 17,005 | | | | | $ | 21,051 | | | | | $ | 26,599 | | | | | $ | 31,929 | | | | | $ | 36,460 | | | | | $ | 42,592 | | | | | $ | 50,142 | | | | | $ | 58,972 | | |
Cost of revenue(1)
|
| | | | 2,494 | | | | | | 3,430 | | | | | | 3,997 | | | | | | 4,591 | | | | | | 4,883 | | | | | | 6,333 | | | | | | 6,681 | | | | | | 7,924 | | |
Gross profit
|
| | | | 14,511 | | | | | | 17,621 | | | | | | 22,602 | | | | | | 27,338 | | | | | | 31,577 | | | | | | 36,259 | | | | | | 43,461 | | | | | | 51,048 | | |
Operating Expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development(1)
|
| | | | 4,055 | | | | | | 11,982 | | | | | | 5,119 | | | | | | 6,651 | | | | | | 12,781 | | | | | | 12,620 | | | | | | 11,428 | | | | | | 15,581 | | |
Sales and marketing(1)
|
| | | | 26,706 | | | | | | 33,296 | | | | | | 30,384 | | | | | | 36,945 | | | | | | 39,636 | | | | | | 57,871 | | | | | | 56,901 | | | | | | 63,048 | | |
General and administrative(1)
|
| | | | 2,657 | | | | | | 8,626 | | | | | | 2,802 | | | | | | 3,745 | | | | | | 7,351 | | | | | | 6,415 | | | | | | 36,828 | | | | | | 10,266 | | |
Total operating expenses
|
| | | | 33,418 | | | | | | 53,904 | | | | | | 38,305 | | | | | | 47,341 | | | | | | 59,768 | | | | | | 76,906 | | | | | | 105,157 | | | | | | 88,895 | | |
Operating loss
|
| | | | (18,907) | | | | | | (36,283) | | | | | | (15,703) | | | | | | (20,003) | | | | | | (28,191) | | | | | | (40,647) | | | | | | (61,696) | | | | | | (37,847) | | |
Financial income (expense), net
|
| | | | 509 | | | | | | 483 | | | | | | 573 | | | | | | 349 | | | | | | 141 | | | | | | 239 | | | | | | (203) | | | | | | (406) | | |
Loss before income taxes
|
| | | | (18,398) | | | | | | (35,800) | | | | | | (15,130) | | | | | | (19,654) | | | | | | (28,050) | | | | | | (40,408) | | | | | | (61,899) | | | | | | (38,253) | | |
Income tax expenses
|
| | | | (24) | | | | | | (42) | | | | | | (590) | | | | | | (209) | | | | | | (350) | | | | | | (671) | | | | | | (962) | | | | | | (699) | | |
Net loss
|
| | | $ | (18,422) | | | | | $ | (35,842) | | | | | $ | (15,720) | | | | | $ | (19,863) | | | | | $ | (28,400) | | | | | $ | (41,079) | | | | | $ | (62,861) | | | | | $ | (38,952) | | |
| | |
Three months ended
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
June 30,
2019 |
| |
September 30,
2019 |
| |
December 31,
2019 |
| |
March 31,
2020 |
| |
June 30,
2020 |
| |
September 30,
2020 |
| |
December 31,
2020 |
| |
March 31,
2021 |
| ||||||||||||||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||||||||||||||||||||||||||
Cost of revenue
|
| | | $ | 146 | | | | | $ | 535 | | | | | $ | 236 | | | | | $ | 299 | | | | | $ | 603 | | | | | $ | 843 | | | | | $ | 975 | | | | | $ | 1,531 | | |
Research and development
|
| | | | 517 | | | | | | 7,636 | | | | | | 725 | | | | | | 1,025 | | | | | | 5,594 | | | | | | 3,346 | | | | | | 2,177 | | | | | | 4,537 | | |
Sales and marketing
|
| | | | 265 | | | | | | 1,781 | | | | | | 740 | | | | | | 1,051 | | | | | | 2,706 | | | | | | 3,183 | | | | | | 3,128 | | | | | | 4,034 | | |
General and administrative
|
| | | | 533 | | | | | | 6,854 | | | | | | 676 | | | | | | 851 | | | | | | 4,398 | | | | | | 2,424 | | | | | | 31,742 | | | | | | 4,438 | | |
Total share-based compensation expense(2)
|
| | | $ | 1,461 | | | | | $ | 16,806 | | | | | $ | 2,377 | | | | | $ | 3,226 | | | | | $ | 13,301 | | | | | $ | 9,796 | | | | | $ | 38,022 | | | | | $ | 14,540 | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Non-GAAP operating loss
|
| | | $ | (70,679) | | | | | $ | (86,192) | | | | | $ | (16,777) | | | | | $ | (23,307) | | |
Adjusted free cash flow
|
| | | | (38,417) | | | | | | (40,692) | | | | | | (5,959) | | | | | | (1,595) | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Operating loss
|
| | | $ | (92,518) | | | | | $ | (150,537) | | | | | $ | (20,003) | | | | | $ | (37,847) | | |
Share-based compensation expenses
|
| | | | 21,839 | | | | | | 64,345 | | | | | | 3,226 | | | | | | 14,540 | | |
Non-GAAP operating loss
|
| | | $ | (70,679) | | | | | $ | (86,192) | | | | | $ | (16,777) | | | | | $ | (23,307) | | |
| | |
Year ended December 31,
|
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Net cash used in operating activities
|
| | | $ | (36,650) | | | | | $ | (37,175) | | | | | $ | (5,133) | | | | | $ | (599) | | |
Purchase of property and equipment
|
| | | | (1,402) | | | | | | (4,362) | | | | | | (1,142) | | | | | | (4,223) | | |
Capitalized software development costs
|
| | | | (365) | | | | | | (1,119) | | | | | | (109) | | | | | | (440) | | |
Purchase of property and equipment related
to build-out of our new corporate headquarters |
| | | | — | | | | | | 1,964 | | | | | | 425 | | | | | | 3,667 | | |
Adjusted free cash flow
|
| | | $ | (38,417) | | | | | $ | (40,692) | | | | | $ | (5,959) | | | | | $ | (1,595) | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Net cash used in operating activities
|
| | | $ | (36,650) | | | | | $ | (37,175) | | | | | $ | (5,133) | | | | | $ | (599) | | |
Net cash provided by (used in) investing activities
|
| | | | 13,233 | | | | | | (11,481) | | | | | | (1,251) | | | | | | (4,642) | | |
Net cash generated from financing activities
|
| | | | 158,446 | | | | | | 8,470 | | | | | | 2,042 | | | | | | 308 | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
|
Risk-free interest rate
|
| |
2.12% – 2.75%
|
| |
0.3% – 0.58%
|
| |
0.51% – 0.58%
|
| |
0.68% – 0.95%
|
|
Expected dividend yield
|
| |
0%
|
| |
0%
|
| |
0%
|
| |
0%
|
|
Expected term (in years)
|
| |
5 – 8
|
| |
5 – 8
|
| |
5 – 7
|
| |
5 – 8
|
|
Expected volatility
|
| |
43% – 45%
|
| |
47% – 48%
|
| |
46.95%
|
| |
49.05%
|
|
|
Software
HubSpot, Inc. Lightspeed POS Inc. Semrush Holdings, Inc. Canva Pty Ltd. Software AG |
| |
Broadcasting & Telecommunications
Hulu LLC BBC Studios Nielsen Sports America LLC NBC Universal Media, LLC Discovery Channel Priority by O2 |
| |
Consumer Goods
Mars, Incorporated Zippo Manufacturing Company Nautica Apparel Inc. |
| |
Healthcare
Alexion Pharmaceuticals, Inc. NovoCure Limited Oscar Insurance Corporation Sanofi S.A. Bayer AG |
|
|
Music
Universal Music Group Deezer |
| |
Energy
Engie SA Sempra Energy |
| |
Transportation & Machinery
Daimler AG HOLT CAT Carvana Co. |
| |
Financial Services
Cross River Bank American Family Insurance Indosuez Wealth Management |
|
|
Entertainment & Leisure
Peloton Interactive, Inc. National Hockey League Electronic Arts Inc. |
| |
Retail Commerce
Coppel Lojas Riachuelo |
| |
Real Estate & Architecture
Interior Logic Group The Ray White Group (Real Estate) Partnership |
| |
Hospitality
Live! Casino & Hotel The Student Hotel |
|
|
Education & Services
Genpact Limited The United States Army — Defense Media Activity eMarketer Alabama Math, Science, and Technology Initiative |
| | | | | | | | | |
Name
|
| |
Age
|
| |
Position
|
|
Executive Officers | | | | | | | |
Roy Mann | | |
42
|
| | Co-Founder, Co-Chief Executive Officer, Director | |
Eran Zinman | | |
38
|
| | Co-Founder, Co-Chief Executive Officer, Director | |
Eliran Glazer | | |
49
|
| | Chief Financial Officer | |
Daniel Lereya | | |
36
|
| | Vice President of Research & Development and Product | |
Yoni Osherov | | |
43
|
| | Vice President of Global Sales and Marketing | |
Kfir Lippmann(1) | | |
35
|
| | Vice President of Finance | |
Shiran Nawi | | |
37
|
| | General Counsel | |
Directors | | | | | | | |
Aviad Eyal | | |
50
|
| | Director | |
Jeff Horing | | |
56
|
| | Director | |
Avishai Abrahami | | |
50
|
| | Director | |
Gili Iohan(2) | | |
45
|
| | External Director Nominee | |
Ronen Faier(2) | | |
50
|
| | External Director Nominee | |
| | |
Shares Beneficially Owned After Offering
|
| |||||||||||||||||||||||||||
| | |
Shares Beneficially
Owned Prior to Offering |
| |
Assuming
Underwriters’ Option to Purchase Additional Ordinary Shares is Not Exercised |
| |
Assuming
Underwriters’ Option to Purchase Additional Ordinary Shares is Exercised in Full |
| |||||||||||||||||||||
Name of Beneficial Owner
|
| |
Number
|
| |
%
|
| |
Number
|
| |
%
|
| |
Number
|
| |
%
|
| ||||||||||||
Principal Shareholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Insight Partners(1)
|
| | | | 16,592,053 | | | | | | 42.7% | | | | | | | | | % | | | | | | | | | % | | |
Stripes(2) | | | | | 3,039,939 | | | | | | 7.8% | | | | | | | | | % | | | | | | | | | % | | |
Sonnipe Limited(3)
|
| | | | 4,807,795 | | | | | | 12.4% | | | | | | | | | % | | | | | | | | | % | | |
Directors and Executive Officers
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Roy Mann
|
| | | | 5,956,539 | | | | | | 15.3% | | | | | | | | | % | | | | | | | | | % | | |
Eran Zinman(4)
|
| | | | 2,301,844 | | | | | | 5.6% | | | | | | | | | % | | | | | | | | | % | | |
Eliran Glazer
|
| | | | — | | | | | | —% | | | | | | | | | % | | | | | | | | | % | | |
| | |
Shares Beneficially Owned After Offering
|
| |||||||||||||||||||||||||||
| | |
Shares
Beneficially Owned Prior to Offering |
| |
Assuming
Underwriters’ Option to Purchase Additional Ordinary Shares is Not Exercised |
| |
Assuming
Underwriters’ Option to Purchase Additional Ordinary Shares is Exercised in Full |
| |||||||||||||||||||||
Name of Beneficial Owner
|
| |
Number
|
| |
%
|
| |
Number
|
| |
%
|
| |
Number
|
| |
%
|
| ||||||||||||
Daniel Lereya(5)
|
| | | | 72,916 | | | | | | *% | | | | | | | | | % | | | | | | | | | % | | |
Yoni Osherov(6)
|
| | | | 58,983 | | | | | | *% | | | | | | | | | % | | | | | | | | | % | | |
Kfir Lippmann(7)
|
| | | | 47,507 | | | | | | *% | | | | | | | | | % | | | | | | | | | % | | |
Shiran Nawi(8)
|
| | | | 27,678 | | | | | | *% | | | | | | | | | % | | | | | | | | | % | | |
Avishai Abrahami(9)
|
| | | | 1,550,500 | | | | | | 4.0% | | | | | | | | | % | | | | | | | | | % | | |
Aviad Eyal(10)
|
| | | | 739,295 | | | | | | 1.9% | | | | | | | | | % | | | | | | | | | % | | |
Jeff Horing(1)
|
| | | | 16,592,053 | | | | | | 42.7% | | | | | | | | | % | | | | | | | | | % | | |
Gili Iohan
|
| | | | — | | | | | | —% | | | | | | | | | % | | | | | | | | | % | | |
Ronen Faier
|
| | | | — | | | | | | —% | | | | | | | | | % | | | | | | | | | % | | |
All executive officers and directors as a group
(12 persons) |
| | | | 27,347,315 | | | | | | 70.0% | | | | | | | | | % | | | | | | | | | % | | |
Shareholder
|
| |
Series D
Preferred Shares |
| |
Total
Purchase Price |
| ||||||
Stripes III Offshore AIV, LP (formerly known as SG Growth Partners III Offshore AIV, LP)
|
| | | | 819,548 | | | | | $ | 11,195,927.90 | | |
Stripes IV Offshore AIV, LP (formerly known as SG Growth Partners IV
Offshore AIV, LP) |
| | | | 1,639,096 | | | | | $ | 22,391,855.79 | | |
Sonnipe Limited
|
| | | | 388,509 | | | | | $ | 5,307,456.07 | | |
Insight Venture Partners IX, L.P.
|
| | | | 485,861 | | | | | $ | 6,637,400.17 | | |
Insight Venture Partners (Cayman) IX, L.P.
|
| | | | 241,413 | | | | | $ | 3,297,969.35 | | |
Insight Venture Partners IX (Delaware), L.P.
|
| | | | 51,477 | | | | | $ | 703,232.91 | | |
Insight Venture Partners IX (Co-Investors), L.P.
|
| | | | 9,698 | | | | | $ | 132,485.44 | | |
Aviad Eyal
|
| | | | 24,425 | | | | | $ | 333,672.37 | | |
Shareholder
|
| |
Series E
Preferred Shares |
| |
Total
Purchase Price |
| ||||||
Sapphire Ventures Fund IV, L.P.
|
| | | | 706,712 | | | | | $ | 29,166,667 | | |
Sapphire Opportunity Fund, L.P.
|
| | | | 504,794 | | | | | $ | 20,833,333 | | |
| | |
Number of Ordinary
Shares |
|
Goldman Sachs & Co. LLC
|
| |
|
|
J.P. Morgan Securities LLC
|
| | | |
Allen & Company LLC
|
| | | |
Jefferies LLC
|
| | | |
William Blair & Company, L.L.C.
|
| | | |
Piper Sandler & Co.
|
| | | |
Oppenheimer & Co. Inc.
|
| | | |
Canaccord Genuity LLC
|
| | | |
Cowen and Company, LLC
|
| | | |
Needham & Company, LLC
|
| | | |
Total | | | | |
| | |
No Exercise
|
| |
Full Exercise
|
| ||||||
Per Ordinary Share
|
| | | $ | | | | | $ | | | ||
Total
|
| | | $ | | | | | $ | | | |
Expenses
|
| |
Amount
|
| |||
SEC registration fee
|
| | | $ | * | | |
FINRA filing fee
|
| | | | * | | |
Stock exchange listing fee
|
| | | | * | | |
Transfer agent’s fee
|
| | | | * | | |
Printing and engraving expenses
|
| | | | * | | |
Legal fees and expenses
|
| | | | * | | |
Accounting fees and expenses
|
| | | | * | | |
Miscellaneous costs
|
| | | | * | | |
Total
|
| | | | * | | |
| | |
Page
|
| |||
| | | | F-2 | | | |
| | | | F-3 | | | |
| | | | F-4 | | | |
| | | | F-5 | | | |
| | | | F-6 | | | |
| | | | F-7 – F-31 | | |
| | |
December 31,
|
| |
March 31,
2021 |
| |
Pro forma
Shareholders’ Equity March 31, 2021 |
| |||||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |
(Unaudited)
|
| ||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | |
CURRENT ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 171,601 | | | | | $ | 129,814 | | | | | $ | 124,281 | | | | | | | | |
Short term deposits
|
| | | | 4,000 | | | | | | 10,000 | | | | | | 10,000 | | | | | | | | |
Accounts receivable – net of allowance for doubtful accounts of $21, $264,
and $410 as of December 31, 2019 and 2020 and March 31, 2021 (unaudited), respectively |
| | | | 3,439 | | | | | | 3,911 | | | | | | 4,897 | | | | | | | | |
Prepaid expenses and other current assets
|
| | | | 2,269 | | | | | | 3,898 | | | | | | 6,572 | | | | | | | | |
Total current assets
|
| | | | 181,309 | | | | | | 147,623 | | | | | | 145,750 | | | | | | | | |
Property and equipment, net
|
| | | | 3,194 | | | | | | 7,178 | | | | | | 11,486 | | | | | | | | |
Other long-term assets
|
| | | | 645 | | | | | | 2,619 | | | | | | 3,243 | | | | | | | | |
Total assets
|
| | | $ | 185,148 | | | | | $ | 157,420 | | | | | $ | 160,479 | | | | | | | | |
LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS’ (DEFICIT) EQUITY
|
| | | | | | | | | | | | | | | | | | | | | | | | |
CURRENT LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 18,950 | | | | | $ | 25,734 | | | | | $ | 29,677 | | | | | | | | |
Accrued expenses and other current liabilities
|
| | | | 7,800 | | | | | | 22,967 | | | | | | 28,526 | | | | | | | | |
Deferred revenue
|
| | | | 40,981 | | | | | | 70,719 | | | | | | 87,703 | | | | | | | | |
Revolving credit facility
|
| | | | 13,030 | | | | | | 21,016 | | | | | | 21,037 | | | | | | | | |
Total current liabilities
|
| | | | 80,761 | | | | | | 140,436 | | | | | | 166,943 | | | | | | | | |
Other long-term liabilities
|
| | | | 1,512 | | | | | | 1,045 | | | | | | 1,182 | | | | | | | | |
Total liabilities
|
| | | | 82,273 | | | | | | 141,481 | | | | | | 168,125 | | | | | | | | |
COMMITMENTS AND CONTINGENCIES (NOTE 7) | | | | | | | | | | | | | | | | | | | | | | | | | |
CONVERTIBLE PREFERRED SHARES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Preferred shares, no par value – Authorized: 27,056,939 shares as of December 31, 2019 and 2020 and March 31, 2021 (unaudited); Issued and outstanding: 26,440,239 as of December 31, 2019 and 2020 and March 31, 2021 (unaudited); Aggregate liquidation preference of $233,915 as of December 31, 2019 and 2020 and March 31, 2021 (unaudited); Pro forma: no shares issued and outstanding as of March 31, 2021 (unaudited)
|
| | | | 233,496 | | | | | | 233,496 | | | | | | 233,496 | | | | | | — | | |
SHAREHOLDERS’ (DEFICIT) EQUITY: | | | | | | | | | | | | | | | | | | | | | | | | | |
Ordinary shares, no par value – Authorized: 52,943,061 shares as of
December 31, 2019 and 2020 and March 31, 2021 (unaudited); Issued and Outstanding: 11,772,038, 12,354,471 and 12,451,895 as of December 31, 2019 and 2020 and March 31, 2021 (unaudited) respectively; pro forma: 38,892,134 shares issued and outstanding as of March 31, 2021 (unaudited) |
| | | | — | | | | | | — | | | | | | — | | | | | | | | |
Additional paid-in capital
|
| | | | 33,542 | | | | | | 98,809 | | | | | | 114,176 | | | | | | 347,672 | | |
Accumulated deficit
|
| | | | (164,163) | | | | | | (316,366) | | | | | | (355,318) | | | | | | (355,318) | | |
Total shareholders’ deficit
|
| | | | (130,621) | | | | | | (217,557) | | | | | | (241,142) | | | | | $ | (7,646) | | |
Total liabilities, convertible preferred shares, and shareholders’ deficit
|
| | | $ | 185,148 | | | | | $ | 157,420 | | | | | $ | 160,479 | | | | | | | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |
(Unaudited)
|
| ||||||
Revenue
|
| | | $ | 78,089 | | | | | $ | 161,123 | | | | | $ | 31,929 | | | | | $ | 58,972 | | |
Cost of revenue
|
| | | | 11,978 | | | | | | 22,488 | | | | | | 4,591 | | | | | | 7,924 | | |
Gross profit
|
| | | | 66,111 | | | | | | 138,635 | | | | | | 27,338 | | | | | | 51,048 | | |
OPERATING EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development
|
| | | | 24,637 | | | | | | 43,480 | | | | | | 6,651 | | | | | | 15,581 | | |
Sales and marketing
|
| | | | 118,534 | | | | | | 191,353 | | | | | | 36,945 | | | | | | 63,048 | | |
General and administrative
|
| | | | 15,458 | | | | | | 54,339 | | | | | | 3,745 | | | | | | 10,266 | | |
Total operating expenses
|
| | | | 158,629 | | | | | | 289,172 | | | | | | 47,341 | | | | | | 88,895 | | |
Operating loss
|
| | | | (92,518) | | | | | | (150,537) | | | | | | (20,003) | | | | | | (37,847) | | |
Financial income
|
| | | | 2,359 | | | | | | 1,537 | | | | | | 631 | | | | | | 78 | | |
Financial expenses
|
| | | | (769) | | | | | | (1,011) | | | | | | (282) | | | | | | (484) | | |
Loss before income taxes
|
| | | | (90,928) | | | | | | (150,011) | | | | | | (19,654) | | | | | | (38,253) | | |
Income tax expense
|
| | | | (683) | | | | | | (2,192) | | | | | | (209) | | | | | | (699) | | |
Net loss
|
| | | $ | (91,611) | | | | | $ | (152,203) | | | | | $ | (19,863) | | | | | $ | (38,952) | | |
Net loss per share attributable to ordinary
shareholders’, basic and diluted |
| | | $ | (9.22) | | | | | $ | (14.19) | | | | | $ | (2.08) | | | | | $ | (3.52) | | |
Weighted-average ordinary shares used in calculating net loss per ordinary share, basic and diluted
|
| | | | 11,348,428 | | | | | | 12,048,909 | | | | | | 11,778,108 | | | | | | 12,392,298 | | |
Pro forma net loss per share (unaudited)
|
| | | | | | | | | $ | (3.95) | | | | | | (0.52) | | | | | $ | (1.00) | | |
Weighted-average shares used in calculating pro forma net loss per share, basic and diluted (unaudited)
|
| | | | | | | | | | 38,489,148 | | | | | | 38,218,347 | | | | | | 38,832,537 | | |
| | |
Convertible Preferred Shares
|
| | |
Number of
Ordinary Shares |
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Shareholders’
Deficit |
| |||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | ||||||||||||||||||||||||||||||
Balance as of January 1, 2019
|
| | | | 22,805,727 | | | | | $ | 83,646 | | | | | | | 11,017,137 | | | | | $ | 11,500 | | | | | $ | (72,552) | | | | | $ | (61,052) | | |
Exercise of options
|
| | | | — | | | | | | — | | | | | | | 754,901 | | | | | | 103 | | | | | | — | | | | | | 103 | | |
Share-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | 21,939 | | | | | | — | | | | | | 21,939 | | |
Issuance of Series E preferred shares, net(*)
|
| | | | 3,634,512 | | | | | | 149,850 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | (91,611) | | | | | | (91,611) | | |
Balance as of December 31, 2019
|
| | | | 26,440,239 | | | | | $ | 233,496 | | | | | | | 11,772,038 | | | | | $ | 33,542 | | | | | $ | (164,163) | | | | | $ | (130,621) | | |
Exercise of options
|
| | | | — | | | | | | — | | | | | | | 582,433 | | | | | | 542 | | | | | | — | | | | | | 542 | | |
Share based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | 64,725 | | | | | | — | | | | | | 64,725 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | (152,203) | | | | | | (152,203) | | |
Balance as of December 31, 2020
|
| | | | 26,440,239 | | | | | $ | 233,496 | | | | | | | 12,354,471 | | | | | $ | 98,809 | | | | | $ | (316,366) | | | | | $ | (217,557) | | |
Exercise of options
|
| | | | — | | | | | | — | | | | | | | 97,424 | | | | | | 543 | | | | | | — | | | | | | 543 | | |
Share based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | 14,824 | | | | | | — | | | | | | 14,824 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | (38,952) | | | | | | (38,952) | | |
Balance as of March 31, 2021 (unaudited)
|
| | | | 26,440,239 | | | | | $ | 233,496 | | | | | | | 12,451,895 | | | | | $ | 114,176 | | | | | $ | (355,318) | | | | | $ | (241,142) | | |
| | |
Convertible Preferred Shares
|
| | |
Number of
Ordinary Shares |
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Shareholders’
Deficit |
| |||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | ||||||||||||||||||||||||||||||
Balance as of January 1, 2020
|
| | | | 26,440,239 | | | | | $ | 233,496 | | | | | | | 11,772,038 | | | | | $ | 33,542 | | | | | $ | (164,163) | | | | | $ | (130,621) | | |
Exercise of options
|
| | | | — | | | | | | — | | | | | | | 14,409 | | | | | | 60 | | | | | | — | | | | | | 60 | | |
Share based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | 3,255 | | | | | | — | | | | | | 3,255 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | (19,863) | | | | | | (19,863) | | |
Balance as of March 31, 2020 (unaudited)
|
| | | | 26,440,239 | | | | | $ | 233,496 | | | | | | | 11,786,447 | | | | | $ | 36,857 | | | | | $ | (184,026) | | | | | $ | (147,169) | | |
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| | | | ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| | ||||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |
(Unaudited)
|
| | | | ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | | | | | | ||||||||||||
Net loss
|
| | | $ | (91,611) | | | | | $ | (152,203) | | | | | $ | (19,863) | | | | | $ | (38,952) | | | | | |
Adjustments to reconcile net loss to cash used in operating activities: | | | | | | | | | | | | | | | | | ||||||||||||
Depreciation and amortization
|
| | | | 579 | | | | | | 1,888 | | | | | | 346 | | | | | | 547 | | | | ||
Capital loss from sale of property and equipment
|
| | | | — | | | | | | — | | | | | | — | | | | | | 45 | | | | ||
Share-based compensation
|
| | | | 21,839 | | | | | | 64,345 | | | | | | 3,226 | | | | | | 14,540 | | | | ||
Change in accrued interest on revolving credit facility
|
| | | | 21 | | | | | | (14) | | | | | | (6) | | | | | | 21 | | | | ||
Changes in operating assets and liabilities: | | | | | | | | | | | | | | | | | ||||||||||||
Accounts receivable, net
|
| | | | (3,101) | | | | | | (472) | | | | | | 330 | | | | | | (986) | | | | ||
Prepaid expenses and other assets
|
| | | | (1,313) | | | | | | (1,828) | | | | | | (1,911) | | | | | | (1,629) | | | | ||
Accounts payable
|
| | | | 8,886 | | | | | | 6,773 | | | | | | 3,705 | | | | | | 3,969 | | | | ||
Accrued expenses and other liabilities
|
| | | | 5,555 | | | | | | 14,598 | | | | | | 826 | | | | | | 4,862 | | | | ||
Deferred revenue
|
| | | | 22,495 | | | | | | 29,738 | | | | | | 8,214 | | | | | | 16,984 | | | | ||
Net cash used in operating activities
|
| | | | (36,650) | | | | | | (37,175) | | | | | | (5,133) | | | | | | (599) | | | | ||
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | | | | | ||||||||||||
Purchase of property and equipment
|
| | | | (1,402) | | | | | | (4,362) | | | | | | (1,142) | | | | | | (4,223) | | | | ||
Capitalized software development costs
|
| | | | (365) | | | | | | (1,119) | | | | | | (109) | | | | | | (440) | | | | ||
Proceeds from sale of property and equipment
|
| | | | — | | | | | | — | | | | | | — | | | | | | 21 | | | | ||
Changes in short-term deposits
|
| | | | 15,000 | | | | | | (6,000) | | | | | | — | | | | | | — | | | | ||
Net cash provided by (used in) investing activities
|
| | | | 13,233 | | | | | | (11,481) | | | | | | (1,251) | | | | | | (4,642) | | | | ||
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | | | | | ||||||||||||
Proceeds from issuance of preferred shares
|
| | | | 149,850 | | | | | | — | | | | | | — | | | | | | — | | | | ||
Proceeds from exercise of share options
|
| | | | 103 | | | | | | 542 | | | | | | 60 | | | | | | 543 | | | | ||
Payments in connection with deferred offering costs
|
| | | | — | | | | | | — | | | | | | — | | | | | | (207) | | | | ||
Receipt of revolving credit facility, net of payments
|
| | | | 8,500 | | | | | | 8,000 | | | | | | 2,000 | | | | | | — | | | | ||
Capital lease payments
|
| | | | (7) | | | | | | (72) | | | | | | (18) | | | | | | (28) | | | | ||
Net cash provided by financing activities
|
| | | | 158,446 | | | | | | 8,470 | | | | | | 2,042 | | | | | | 308 | | | | ||
INCREASE (DEACREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
|
| | | | 135,029 | | | | | | (40,186) | | | | | | (4,342) | | | | | | (4,933) | | | | ||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH – Beginning of period
|
| | | | 36,971 | | | | | | 172,000 | | | | | | 172,000 | | | | | | 131,814 | | | | ||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH – End of period
|
| | | $ | 172,000 | | | | | $ | 131,814 | | | | | $ | 167,658 | | | | | $ | 126,881 | | | | | |
SUPPLEMENTAL DISCLOSURE: | | | | | | | | | | | | | | | | | ||||||||||||
Cash paid for taxes
|
| | | $ | 250 | | | | | $ | 2,487 | | | | | $ | 55 | | | | | $ | 18 | | | | | |
Cash paid for interest
|
| | | $ | 522 | | | | | $ | 685 | | | | | $ | 187 | | | | | $ | 133 | | | | | |
NON-CASH INVESTING AND FINANCING ACTIVITIES: | | | | | | | | | | | | | | | | | ||||||||||||
Additions to capital leases
|
| | | $ | 254 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | |
Non-cash purchases of property and equipment
|
| | | $ | 221 | | | | | $ | 232 | | | | | •$ | 370 | | | | | $ | 206 | | | | | |
Unpaid deferred offering costs
|
| | | $ | — | | | | | $ | 174 | | | | | $ | — | | | | | $ | 1,036 | | | | | |
Share-based compensation included in capitalized software development costs
|
| | | $ | 100 | | | | | $ | 380 | | | | | $ | 29 | | | | | $ | 284 | | | | | |
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEET:
|
| | | | | | | | | | | | | | | | ||||||||||||
Cash and cash equivalents
|
| | | $ | 171,601 | | | | | $ | 129,814 | | | | | $ | 167,271 | | | | | $ | 124,281 | | | | | |
Restricted cash – Included in prepaid expense and other current assets
|
| | | | 20 | | | | | | — | | | | | | 20 | | | | | | 600 | | | | ||
Restricted cash – Included in other long-term assets
|
| | | | 379 | | | | | | 2,000 | | | | | | 367 | | | | | | 2,000 | | | | ||
Total cash, cash equivalents, and restricted cash
|
| | | $ | 172,000 | | | | | $ | 131,814 | | | | | $ | 167,658 | | | | | $ | 126,881 | | | | | |
| | |
Years
|
|
Computers software and electronic equipment
|
| |
3 – 5
|
|
Office furniture and equipment | | |
10 – 14
|
|
Capitalized internal use software | | |
3
|
|
Leasehold improvements | | |
Shorter of the remaining term of the underlying lease, or estimated useful life of the asset
|
|
| | |
Year ended
December 31, |
| |
Three months ended
March 31, |
| ||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
|
| | | | | | | | |
(Unaudited)
|
| |||
Risk-free interest rate
|
| |
2.12% – 2.75%
|
| |
0.3% – 0.58%
|
| |
0.51% – 0.58%
|
| |
0.68% – 0.95%
|
|
Expected dividend yield
|
| |
0%
|
| |
0%
|
| |
0%
|
| |
0%
|
|
Expected term (in years)
|
| |
5 – 8
|
| |
5 – 8
|
| |
5 – 7
|
| |
5 – 8
|
|
Expected volatility
|
| |
43% – 45%
|
| |
47% – 48%
|
| |
46.95%
|
| |
49.05%
|
|
| | |
December 31
|
| |
March 31,
2021 |
| ||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Prepaid expenses
|
| | | $ | 1,789 | | | | | $ | 2,508 | | | | | $ | 3,660 | | |
Government institutions
|
| | | | 374 | | | | | | 767 | | | | | | 1,526 | | |
Other current assets
|
| | | | 106 | | | | | | 623 | | | | | | 1,386 | | |
Total prepaid expenses and other current assets
|
| | | $ | 2,269 | | | | | $ | 3,898 | | | | | $ | 6,572 | | |
| | |
December 31
|
| |
March 31,
2021 |
| ||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Computer, software, and electronic equipment
|
| | | $ | 1,880 | | | | | $ | 3,693 | | | | | $ | 4,188 | | |
Office furniture and equipment
|
| | | | 846 | | | | | | 1,178 | | | | | | 1,116 | | |
Leasehold improvements
|
| | | | 767 | | | | | | 2,995 | | | | | | 6,665 | | |
Capitalized software development costs
|
| | | | 465 | | | | | | 1,964 | | | | | | 2,688 | | |
Capital leases
|
| | | | 254 | | | | | | 254 | | | | | | 254 | | |
Property and equipment, gross
|
| | | | 4,212 | | | | | | 10,084 | | | | | | 14,911 | | |
Less accumulated depreciation and amortization
|
| | | | (1,018) | | | | | | (2,906) | | | | | | (3,425) | | |
Property and equipment, net
|
| | | $ | 3,194 | | | | | $ | 7,178 | | | | | $ | 11,486 | | |
| | |
December 31
|
| |
March 31,
2021 |
| ||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Accrued employee compensation and benefits
|
| | | $ | 3,493 | | | | | $ | 14,210 | | | | | $ | 15,962 | | |
Accrued expenses
|
| | | | 1,504 | | | | | | 4,825 | | | | | | 6,597 | | |
Capital lease – short-term
|
| | | | 84 | | | | | | 88 | | | | | | 85 | | |
Advances from customers
|
| | | | 1,672 | | | | | | 1,556 | | | | | | 2,439 | | |
Income and indirect taxes payable
|
| | | | 1,047 | | | | | | 2,288 | | | | | | 3,443 | | |
Total
|
| | | $ | 7,800 | | | | | $ | 22,967 | | | | | $ | 28,526 | | |
Years Ending December 31,
|
| |
Amount
|
| |||
2021
|
| | | $ | 7,172 | | |
2022
|
| | | | 8,229 | | |
2023
|
| | | | 8,856 | | |
2024
|
| | | | 9,924 | | |
2025
|
| | | | 10,181 | | |
Thereafter
|
| | | | 6,310 | | |
Total minimum lease payments
|
| | | $ | 50,672 | | |
Years Ending December 31,
|
| |
Amount
|
| |||
Remainder of 2021
|
| | | $ | 4,156 | | |
2022
|
| | | | 7,582 | | |
2023
|
| | | | 8,582 | | |
2024
|
| | | | 9,653 | | |
2025
|
| | | | 9,866 | | |
Thereafter
|
| | | | 8,139 | | |
Total minimum lease payments
|
| | | $ | 47,978 | | |
Years Ending December 31,
|
| |
Amount
|
| |||
2021
|
| | | $ | 4,295 | | |
2022
|
| | | | 1,600 | | |
Total contractual obligations
|
| | | $ | 5,895 | | |
Years Ending December 31,
|
| |
Amount
|
| |||
Remainder of 2021
|
| | | $ | 1,978 | | |
2022
|
| | | | 1,649 | | |
2023
|
| | | | 92 | | |
Total contractual obligations
|
| | | $ | 3,719 | | |
| | |
Year ended
December 31, |
| |
Three months ended,
March 31 |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Financial expenses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Bank charges and other
|
| | | $ | 226 | | | | | $ | 340 | | | | | $ | 101 | | | | | $ | 145 | | |
Interest on credit facility and amortization of debt issuance fees
|
| | | | 543 | | | | | | 671 | | | | | | 181 | | | | | | 173 | | |
Exchange rate expense, net
|
| | | | — | | | | | | — | | | | | | — | | | | | | 166 | | |
Total financial expenses
|
| | | | 769 | | | | | | 1,011 | | | | | | 282 | | | | | | 484 | | |
Financial income: | | | | | | | | | | | | | | | | | | | | | | | | | |
Exchange rate income, net
|
| | | | 115 | | | | | | 492 | | | | | | 146 | | | | | | — | | |
Interest income on deposits
|
| | | | 2,244 | | | | | | 1,045 | | | | | | 485 | | | | | | 78 | | |
Total financial income
|
| | | | 2,359 | | | | | | 1,537 | | | | | | 631 | | | | | | 78 | | |
Financial income (expenses), net
|
| | | $ | 1,590 | | | | | $ | 526 | | | | | $ | 349 | | | | | $ | (406) | | |
| | |
Authorized
|
| |
Issued and
Outstanding |
| |
Issuance Price
Per Share |
| |
Carrying
Value, Net |
| ||||||||||||
Series A
|
| | | | 5,000,000 | | | | | | 4,383,300 | | | | | $ | 0.30 | | | | | $ | 1,280 | | |
Series B
|
| | | | 4,619,000 | | | | | | 4,619,000 | | | | | | 1.08 | | | | | | 4,970 | | |
Series B-1
|
| | | | 1,563,400 | | | | | | 1,563,400 | | | | | | 0.70 | | | | | | 1,100 | | |
Series B-2
|
| | | | 1,938,100 | | | | | | 1,938,100 | | | | | | 0.77 | | | | | | 1,496 | | |
Series C
|
| | | | 6,641,900 | | | | | | 6,641,900 | | | | | | 3.76 | | | | | | 24,925 | | |
Series D
|
| | | | 3,660,027 | | | | | | 3,660,027 | | | | | | 13.66 | | | | | | 49,875 | | |
Series E
|
| | | | 3,634,512 | | | | | | 3,634,512 | | | | | | 41.27 | | | | | | 149,850 | | |
Total
|
| | | | 27,056,939 | | | | | | 26,440,239 | | | | | | | | | | | $ | 233,496 | | |
| | |
December 31
|
| |
March 31,
2021 |
| ||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Conversion of Preferred shares: | | | | | |||||||||||||||
Series A
|
| | | | 4,383,300 | | | | | | 4,383,300 | | | | | | 4,383,300 | | |
Series B
|
| | | | 4,619,000 | | | | | | 4,619,000 | | | | | | 4,619,000 | | |
Series B-1
|
| | | | 1,563,400 | | | | | | 1,563,400 | | | | | | 1,563,400 | | |
Series B-2
|
| | | | 1,938,100 | | | | | | 1,938,100 | | | | | | 1,938,100 | | |
Series C
|
| | | | 6,641,900 | | | | | | 6,641,900 | | | | | | 6,641,900 | | |
Series D
|
| | | | 3,660,027 | | | | | | 3,660,027 | | | | | | 3,660,027 | | |
Series E
|
| | | | 3,634,512 | | | | | | 3,634,512 | | | | | | 3,634,512 | | |
Ordinary shares
|
| | | | 11,772,038 | | | | | | 12,354,471 | | | | | | 12,451,895 | | |
Outstanding share options
|
| | | | 4,684,239 | | | | | | 5,909,263 | | | | | | 7,091,672 | | |
Shares available for future grants under the 2017 plan
|
| | | | 3,140,366 | | | | | | 1,332,909 | | | | | | 178,168 | | |
Total
|
| | | | 46,036,882 | | | | | | 46,036,882 | | | | | | 46,161,974 | | |
| | |
Number of
Options |
| |
Weighted-
Average Exercise Price |
| |
Weighted
Average Remaining Contractual life |
| |
Aggregate
Intrinsic Value |
| ||||||||||||
Outstanding – January 1, 2019
|
| | | | 4,642,783 | | | | | $ | 0.47 | | | | | | 7.64 | | | | | | 42,703 | | |
Granted
|
| | | | 1,234,049 | | | | | $ | 5.02 | | | | | | | | | | | | | | |
Exercised
|
| | | | (754,901) | | | | | $ | 0.13 | | | | | | | | | | | | | | |
Expired and forfeited
|
| | | | (437,692) | | | | | $ | 2.21 | | | | | | | | | | | | | | |
Outstanding – December 31, 2019
|
| | | | 4,684,239 | | | | | $ | 1.56 | | | | | | 7.38 | | | | | | 112,744 | | |
Exercisable – December 31, 2019
|
| | | | 3,053,009 | | | | | $ | 0.58 | | | | | | 6.69 | | | | | | 76,463 | | |
Outstanding – January 1, 2020
|
| | | | 4,684,239 | | | | | $ | 1.56 | | | | | | 7.38 | | | | | | 112,744 | | |
Granted
|
| | | | 2,076,131 | | | | | $ | 11.54 | | | | | | | | | | | | | | |
Exercised
|
| | | | (582,433) | | | | | $ | 0.93 | | | | | | | | | | | | | | |
Expired and forfeited
|
| | | | (268,674) | | | | | $ | 9.32 | | | | | | | | | | | | | | |
Outstanding – December 31, 2020
|
| | | | 5,909,263 | | | | | $ | 4.79 | | | | | | 7.5 | | | | | | 341,152 | | |
Exercisable – December 31, 2020
|
| | | | 3,916,562 | | | | | $ | 1.37 | | | | | | 6.77 | | | | | | 239,508 | | |
Outstanding – January 1, 2021
|
| | | | 5,909,263 | | | | | $ | 4.79 | | | | | | 7.5 | | | | | | 341,152 | | |
Granted
|
| | | | 1,352,829 | | | | | $ | 20.04 | | | | | | | | | | | | | | |
Exercised
|
| | | | (97,424) | | | | | $ | 5.59 | | | | | | | | | | | | | | |
Expired and forfeited
|
| | | | (72,996) | | | | | $ | 19.74 | | | | | | | | | | | | | | |
Outstanding – March 31, 2021 (unaudited)
|
| | | | 7,091,672 | | | | | $ | 7.76 | | | | | | 7.74 | | | | | | 585,505 | | |
Exercisable – March 31, 2021 (unaudited)
|
| | | | 4,074,085 | | | | | $ | 1.83 | | | | | | 6.62 | | | | | | 359,944 | | |
| | |
December 31,
|
| |
March 31,
|
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Cost of revenues
|
| | | $ | 970 | | | | | $ | 2,720 | | | | | $ | 299 | | | | | $ | 1,531 | | |
Research and development
|
| | | | 9,396 | | | | | | 12,142 | | | | | | 1,025 | | | | | | 4,537 | | |
Sales and marketing
|
| | | | 3,283 | | | | | | 10,068 | | | | | | 1,051 | | | | | | 4,034 | | |
General and administrative(*)
|
| | | | 8,190 | | | | | | 39,415 | | | | | | 851 | | | | | | 4,438 | | |
Share-based compensation, net of amounts capitalized
|
| | | $ | 21,839 | | | | | $ | 64,345 | | | | | $ | 3,226 | | | | | $ | 14,540 | | |
Capitalized share-based compensation expense
|
| | | | 100 | | | | | | 380 | | | | | | 29 | | | | | | 284 | | |
Total share-based compensation
|
| | | $ | 21,939 | | | | | $ | 64,725 | | | | | $ | 3,255 | | | | | $ | 14,824 | | |
| | |
2019
|
| |
2020
|
| ||||||
Domestic (Israel)
|
| | | $ | (91,788) | | | | | $ | (152,335) | | |
Foreign
|
| | | | 860 | | | | | | 2,324 | | |
Total
|
| | | $ | (90,928) | | | | | $ | (150,011) | | |
| | |
2019
|
| |
2020
|
| ||||||
Domestic (Israel)
|
| | | $ | 249 | | | | | $ | 243 | | |
Foreign
|
| | | | 434 | | | | | | 1,949 | | |
Total
|
| | | $ | 683 | | | | | $ | 2,192 | | |
| | |
Year ended December 31,
|
| |||||||||||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||||||||
| | |
Tax
|
| |
Rate
|
| |
Tax
|
| |
Rate
|
| ||||||||||||
Theoretical tax benefit
|
| | | $ | (20,914) | | | | | | 23% | | | | | $ | (34,503) | | | | | | 23% | | |
Increase (decrease) in tax rate due to: | | | | | | | | | | | | | | | | | | | | | | | | | |
Change in valuation allowance
|
| | | | 10,562 | | | | | | (12)% | | | | | | 14,622 | | | | | | (10)% | | |
Share-based compensation
|
| | | | 2,742 | | | | | | (3)% | | | | | | 8,324 | | | | | | (5)% | | |
Preferred technological enterprise
|
| | | | 10,097 | | | | | | (11)% | | | | | | 16,757 | | | | | | (11)% | | |
Currency differences
|
| | | | (1,796) | | | | | | 2% | | | | | | (2,998) | | | | | | 2% | | |
Other
|
| | | | (8) | | | | | | 0% | | | | | | (10) | | | | | | 0% | | |
Effective tax
|
| | | $ | 683 | | | | | | (1)% | | | | | $ | 2,192 | | | | | | (1)% | | |
| | |
December 31
|
| |||||||||
| | |
2019
|
| |
2020
|
| ||||||
Deferred tax assets:
|
| | | | | | | | | | | | |
Net operating loss carry forwards
|
| | | $ | 15,456 | | | | | $ | 27,148 | | |
Research and development
|
| | | | 1,613 | | | | | | 3,296 | | |
Other temporary differences
|
| | | | 233 | | | | | | 1,414 | | |
Carryforward tax credits
|
| | | | 262 | | | | | | 601 | | |
Gross deferred tax assets
|
| | | | 17,564 | | | | | | 32,459 | | |
Valuation allowance
|
| | | | (17,482) | | | | | | (32,104) | | |
Total deferred tax assets
|
| | | | 82 | | | | | | 355 | | |
Deferred tax liabilities:
|
| | | | | | | | | | | | |
Depreciation
|
| | | | (82) | | | | | | (355) | | |
Deferred tax liabilities
|
| | | | (82) | | | | | | (355) | | |
Net deferred taxes
|
| | | $ | — | | | | | $ | — | | |
| | |
Year ended
December 31 |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Numerator: | | | | | | ||||||||||||||||||||
Net loss
|
| | | $ | 91,611 | | | | | $ | 152,203 | | | | | $ | 19,863 | | | | | $ | 38,952 | | |
Undistributed earnings attributable to preferred shareholders
|
| | | | 13,058 | | | | | | 18,713 | | | | | | 4,665 | | | | | | 4,614 | | |
Net loss attributable to ordinary shareholders, basic and diluted
|
| | | $ | 104,669 | | | | | $ | 170,916 | | | | | $ | 24,528 | | | | | $ | 43,566 | | |
Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average ordinary shares outstanding
|
| | | | 11,348,428 | | | | | | 12,048,909 | | | | | | 11,778,108 | | | | | | 12,392,298 | | |
Basic and diluted net loss per share
|
| | | $ | (9.22) | | | | | $ | (14.19) | | | | | $ | (2.08) | | | | | $ | (3.52) | | |
| | |
Year ended
December 31 |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
Numerator: | | | | | | ||||||||||||||||||||
Net loss and pro forma net loss
|
| | | $ | 91,611 | | | | | $ | 152,203 | | | | | $ | 19,863 | | | | | $ | 38,952 | | |
Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average ordinary shares outstanding
|
| | | | 11,348,428 | | | | | | 12,048,909 | | | | | | 11,778,108 | | | | | | 12,392,298 | | |
Conversion of convertible Preferred shares
|
| | | | 24,727,537 | | | | | | 26,440,239 | | | | | | 26,440,239 | | | | | | 26,440,239 | | |
Weighted average shares used in computing pro forma net loss per share
|
| | | | 36,075,965 | | | | | | 38,489,148 | | | | | | 38,218,347 | | | | | | 38,832,537 | | |
Basic and diluted net loss per share
|
| | | $ | (2.54) | | | | | $ | (3.95) | | | | | $ | (0.52) | | | | | $ | (1.00) | | |
| | |
Year ended
December 31 |
| |
Three months ended
March 31, |
| ||||||||||||||||||
| | |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||||||||
United States
|
| | | $ | 36,439 | | | | | $ | 77,933 | | | | | $ | 15,296 | | | | | $ | 28,268 | | |
EMEA
|
| | | | 24,809 | | | | | | 49,747 | | | | | | 9,859 | | | | | | 18,578 | | |
Rest of the world
|
| | | | 16,841 | | | | | | 33,443 | | | | | | 6,774 | | | | | | 12,126 | | |
| | | | $ | 78,089 | | | | | $ | 161,123 | | | | | $ | 31,929 | | | | | $ | 58,972 | | |
| | |
As of
December 31 |
| |
As of
March 31, 2021 |
| ||||||||||||
| | |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(Unaudited)
|
| |||
Israel
|
| | | $ | 3,019 | | | | | $ | 6,361 | | | | | $ | 10,530 | | |
United States
|
| | | | 175 | | | | | | 756 | | | | | | 764 | | |
Rest of the world
|
| | | | — | | | | | | 61 | | | | | | 192 | | |
| | | | $ | 3,194 | | | | | $ | 7,178 | | | | | $ | 11,486 | | |
|
Exhibit
No. |
| |
Description
|
| ||||
| | | 1 | .1* | | | | Form of Underwriting Agreement | |
| | | 3 | .1** | | | | | |
| | | 3 | .2* | | | |
Form of Amended and Restated Articles of Association of the Registrant to become effective
upon closing of this offering |
|
| | | 4 | .1 | | | | | |
| | | 4 | .2** | | | | | |
| | | 5 | .1* | | | | Opinion of Meitar | Law Offices, counsel to the Registrant, as to the validity of the ordinary shares (including consent) | |
| | | 10 | .1* | | | | Form of Indemnification Agreement | |
| | | 10 | .2** | | | | | |
| | | 10 | .3** | | | | | |
| | | 10 | .4* | | | | 2021 Share Incentive Plan | |
| | | 10 | .5* | | | | 2021 Employee Share Purchase Plan | |
| | | 10 | .6* | | | | Compensation Policy for Directors and Officers | |
| | | 10 | .7** | | | | | |
| | | 21 | .1 | | | | | |
| | | 23 | .1 | | | | | |
| | | 23 | .2* | | | | Consent of Meitar | Law Offices (included in Exhibit 5.1) | |
| | | 24 | .1** | | | | | |
| | | 99 | .1** | | | | | |
| | | 99 | .2** | | | | |
|
Name
|
| |
Title
|
|
|
/s/ Roy Mann
Roy Mann
|
| |
Co-Founder and Co-Chief Executive Officer
(Co-Principal Executive Officer) |
|
|
/s/ Eran Zinman
Eran Zinman
|
| |
Co-Founder and Co-Chief Executive Officer
(Co-Principal Executive Officer) |
|
|
/s/ Eliran Glazer
Eliran Glazer
|
| |
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
|
|
*
Avishai Abrahami
|
| | Director | |
|
*
Aviad Eyal
|
| | Director | |
|
*
Jeff Horing
|
| | Director | |
| *By | | | /s/ Eliran Glazer | |
| | | |
Eliran Glazer
Attorney-in-Fact |
|
Exhibit 4.1
|
COUNTERSIGNED AND REGISTERED: AMERICAN STOCK TRANSFER & TRUST COMPANY (Brooklyn, New York) TRANSFER AGENT AND REGISTRAR INCORPORATED UNDER THE LAWS OF ISRAELSEE REVERSE SIDE FOR CERTAIN DEFINITIONS CUSIP 000000 00 0 THIS CERTIFIES THAT BY FULLY PAID AND NON-ASSESSABLE ORDINARY SHARES OF COMMON transferable on the books of the Company by the holder hereof in person or by Attorney upon surrender of this certificate properly endorsed. This certificate is not valid until countersigned and registered by the Transfer Agent and Registrar. AUTHORIZED SIGNATURE Dated: CO-CHIEF EXECUTIVE OFFICERCO-CHIEF EXECUTIVE OFFICER |
|
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: TEN COM – as tenants in commonUTMA – Custodian (Cust)(Minor) TEN ENT– as tenants by entiretiesunder Uniform Transfers to Minors JT TEN– as joint tenants with right of survivorshipAct and not as tenants in common(State) Additional abbreviations may also be used though not in the above list. For value receivedhereby sell, assign, and transfer unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE) Ordinary Shares represented by the within Certificate, and do hereby irrevocably constitute and appoint Attorney to transfer the said stock on the books of the within-named Corporation with full power of substitution in the premises. Dated X X NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER. SIGNATURE GUARANTEED ALL GUARANTEES MUST BE MADE BY A FINANCIAL INSTITUTION (SUCH AS A BANK OR BROKER) WHICH IS A PARTICIPANT IN THE SECURITIES TRANSFER AGENTS MEDALLION PROGRAM (“STAMP”), THE NEW YORK STOCK EXCHANGE, INC. MEDALLION SIGNATURE PROGRAM (“MSP”), OR THE STOCK EXCHANGES MEDALLION PROGRAM (“SEMP”) AND MUST NOT BE DATED. GUARANTEES BY A NOTARY PUBLIC ARE NOT ACCEPTABLE. |
Exhibit 21.1
Subsidiaries of monday.com Ltd.
Name | State or Other Jurisdiction of Incorporation or Organization |
monday.com Inc. | Delaware |
monday.com Pty Ltd. | Australia |
monday.com UK 2020 Ltd. | United Kingdom |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 1 to Registration Statement No. 333-256182 on Form F-1 of our report dated March 11, 2021, relating to the financial statements of monday.com Ltd. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Brightman Almagor Zohar & Co.
Brightman Almagor Zohar & Co.
Certified Public Accountants
A Firm in the Deloitte Global Network
Tel Aviv, Israel
May 24, 2021